Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-008486
Filing Date
2015-11-12
Accepted
2015-11-12 16:08:30
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0915_immucellcorp.htm 10-Q 660909
2 SUPPLY AGREEMENT BETWEEN THE COMPANY AND PLAS-PAK INDUSTRIES, INC. DATED AS OF O f10q0915ex10i_immucell.htm EX-10.1 19472
3 CERTIFICATION f10q0915ex31_immucell.htm EX-31 6743
4 CERTIFICATION f10q0915ex32_immucell.htm EX-32 4173
5 GRAPHIC img01.jpg GRAPHIC 70859
  Complete submission text file 0001213900-15-008486.txt   3774224

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE iccc-20150930.xml EX-101.INS 623613
7 XBRL SCHEMA FILE iccc-20150930.xsd EX-101.SCH 39911
8 XBRL CALCULATION FILE iccc-20150930_cal.xml EX-101.CAL 65482
9 XBRL DEFINITION FILE iccc-20150930_def.xml EX-101.DEF 79922
10 XBRL LABEL FILE iccc-20150930_lab.xml EX-101.LAB 349226
11 XBRL PRESENTATION FILE iccc-20150930_pre.xml EX-101.PRE 230770
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 151224872
SIC: 2835 In Vitro & In Vivo Diagnostic Substances